0001209191-23-023085.txt : 20230404 0001209191-23-023085.hdr.sgml : 20230404 20230404202023 ACCESSION NUMBER: 0001209191-23-023085 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230331 FILED AS OF DATE: 20230404 DATE AS OF CHANGE: 20230404 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Stahler Rachel A CENTRAL INDEX KEY: 0001679854 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40235 FILM NUMBER: 23800779 MAIL ADDRESS: STREET 1: 12701 COMMONWEALTH DRIVE STREET 2: SUITE 9 CITY: FORT MYERS STATE: FL ZIP: 33913 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Organon & Co. CENTRAL INDEX KEY: 0001821825 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 464838035 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 30 HUDSON STREET STREET 2: FL 33 CITY: JERSEY CITY STATE: NJ ZIP: 07302 BUSINESS PHONE: 551-430-6000 MAIL ADDRESS: STREET 1: 30 HUDSON STREET STREET 2: FL 33 CITY: JERSEY CITY STATE: NJ ZIP: 07302 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-03-31 0 0001821825 Organon & Co. OGN 0001679854 Stahler Rachel A C/O ORGANON & CO. 30 HUDSON STREET, FLOOR 33 JERSEY CITY NJ 07302 0 1 0 0 Chief Information Officer 0 Common Stock 2023-03-31 4 M 0 3578 0.00 A 22528 D Common Stock 2023-03-31 4 F 0 1226 23.09 D 21302 D Restricted Stock Units 2023-03-31 4 M 0 3578 0.00 D Common Stock 3578 7157 D Restricted Stock Units 2023-03-31 4 A 0 19664 0.00 A 2024-03-31 2026-03-31 Common Stock 19664 19664 D Stock Option (right to buy) 23.52 2023-03-31 4 A 0 70610 0.00 A 2024-03-31 2033-03-31 Common Stock 70610 70610 D Each Restricted Stock Unit converts into one share of Organon & Co. ("Organon") common stock. On March 31, 2023, one-third of the RSUs vested with the remaining RSUs to vest in two equal installments on March 31, 2024 and March 31, 2025. The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon common stock for each RSU. These RSUs vest and are distributed as shares of Organon common stock in three equal installments on March 31, 2024, March 31, 2025 and March 31, 2026. The Reporting Person was granted stock options, which vest and become exercisable in three equal installments on March 31, 2024, March 31, 2025 and March 31, 2026. /s/ Tarnetta V. Jones, as Attorney-in-Fact for Rachel A. Stahler 2023-04-04